• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

HTA42 The Budget Impact Analysis of Acute Stroke Centre Expansion in Ministry of Health Malaysia
This study aimed to assess the budget impact analysis of expanding acute stroke services/centres in the public healthcare setting in Malaysia. The number of hospitalized stroke cases in the next five years is projected from the latest national stroke registry.
Source: Value in Health - June 26, 2022 Category: International Medicine & Public Health Authors: S Thanimalai, YV Yong, I Looi, WC Law, Aziz Z Abdul Source Type: research

Medicare beneficiary out-of-pocket spending for stroke prevention in non-valvular Atrial Fibrillation: a budget analysis
Healthcare costs today are increasingly being shifted from payers to patients, yet few providers factor patient costs into treatment decisions. Recent advancements in stroke prevention in atrial fibrillation (AF) have resulted in new treatment options where previously there were few. While the clinical benefit and cost effectiveness of these treatments are supported by a growing body of evidence, the cost impact to patients has not been explored. This analysis sought to quantify patient out-of-pocket costs for three stroke prevention strategies: warfarin, dabigatran and left atrial appendage closure (LAAC) with the Watchman Device.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: S. Armstrong, S.L. Amorosi, G. Erickson, P. Patel, K. Stein Source Type: research

PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina
Stroke is responsible for mortality and long-term disability in Argentina. Available treatments for stroke due to Large Vessel Occlusion (LVO) are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). However, despite its clinical benefits, MT coverage in Argentina and PAMI is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in PAMI for the elderly.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina
Stroke is associated with high clinical and economic burden of disease. Available treatments for stroke due to Large Vessel Occlusion (LVO) in Argentina are Thrombolysis (IV-tPA) and Mechanical Thrombectomy (MT). Despite its clinical benefits, MT coverage in Argentina is low. A Budget-Impact Analysis (BIA) was conducted to estimate the financial impact of incorporating MT after IV-TPA in Obras Sociales and Empresas de Medicina Prepaga (EMP) in Argentina.
Source: Value in Health - June 1, 2021 Category: International Medicine & Public Health Authors: P. Lylyk, J. Cirio, C. Toranzo, E.C. Aiello, D. Paredes, J. Valencia Source Type: research

The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation: The Potential Cost And Clinical Impact
Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the United Kingdom and highlight a current shortfall in the prescribing of anticoagulants to patients with AF despite the importance of stroke prevention. A model was designed for use as a planning tool for Clinical Commissioning Groups (CCGs) looking to budget for the future move towards full implementation of the NICE guidelines.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: G.E. Shields, A.M. Chapman Source Type: research

Estimation of Costs Associated With Stroke In Diabetic Patients in Madrid (Spain) Using A New Simulation Model
Diabetes (DM) has a relevant impact on health care budgets mainly due to its high prevalence and its chronic and acute complications. Isquemic stroke (IS) is one of the macrovascular complications associated with DM and its incidence increases with the presence of some risk factors such as hypertension and obesity.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: C. Sánchez-Piedra, S. García-Pérez, A. Sarría-Santamera Source Type: research

Budget Impact Analysis of Botulinium Toxin Type A In Treatment of Post-Stroke Spasticity In The Russian Federation
To conduct budget impact analysis of abobotulinumtoxinA, onabotulinumtoxinA, incobotulinumtoxinA in patients with post-stroke spasticity in Russia for 1-year period. Physical therapy was used in all therapy schemes.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: R. Yagudina, A. Kulikov, D. Ugrekhelidze Source Type: research

Real-World Data And Budget Impact Analysis for Incobotulinum Toxin A and Onabotulinum Toxin A for Upper Limb Post-Stroke Spasticity At A Uk Centre
Botulinum toxins (BT) are a valuable treatment option for patients with post-stroke upper-limb spasticity (PS-ULS), which affects 33,000 patients in the UK. Xeomin (incobotulinum toxin A) and Botox (onabotulinum toxin A) are two BTs licensed for the treatment of PS-ULS. The treatment costs for Xeomin and Botox will depend on their real-world usage.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Robertson, P Datta, J Kusel, S Page, J Soon Source Type: research

Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation
To conduct budget impact analysis of neurotrophic and neuroprotective drug cerebrolysin with standard therapy compared to standard therapy only of ischemic stroke of moderate and severe degrees of severity according to the Russian healthcare system.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Kulikov, G Abdrashitova Source Type: research

Budget Impact Analysis of The Use of Alteplase In The Treatment of Acute Ischaemic Stroke In Mexico
To estimate the economic impact of the use of alteplase versus best supportive care (BSC) in patients with acute ischemic stroke in Mexico.
Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: JL Huicochea-Bartelt, E Palacios, L Zapata, S Herran Tags: CARDIOVASCULAR DISORDERS – Cost Studies Source Type: research

Pharmacoeconomic Analysis of Naftidrofuryl for Ischemic Stroke Treatment
Perform the pharmacoeconomic analysis of including naftidrofuryl into the Russian standards for treatment and rehabilitation of patients suffering from ischemic stroke by means of performing Cost Minimization Analysis (CMA) and Budget Impact Analysis (BIA).
Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: D Belousov, A Cheberda Source Type: research

Budget Impact of Alteplase In Treatment of Acute Ischemic Stroke In Turkey
Cerebrovascular diseases are the sixth cause of total DALYs in Turkey and the Turkish Social Security Institution (SSI) faces a challenge on reimbursement decisions for treatment. Alteplase is a recombinant human tissue plasminogen activator indicated for treatment of acute ischemic stroke (AIS). Clinical trials have proved efficacy in reducing 90-day disability measured by the Modified Rankin Score (mRS) if administered within 4,5 hours of onset of symptoms. The agent is used as an addition to Standard of Care (SoC).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: M Tatar, A Şentürk, E Tetik, L Yıldız, J Cheynel Source Type: research

Budget Impact of Post-Stroke Dysphagia: Database Analyses of Hospital Discharges In France And Switzerland
Oropharyngeal dysphagia is prevalent in hospitalized post-stroke patients and is associated with increased mortality and comorbidities. The aim of our analysis was to evaluate the impact of dysphagia on Length of Hospital Stay (LOS) and costs. The hospital perspective was used to assess costs.
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: N Muehlemann, L de L éotoing, B Jouaneton, J Fernandes, M Arnold, G Kägi Source Type: research

EE460 A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective
MR-001 is an investigational, at-home rehabilitation system designed to improve walking and ambulation status in adults with chronic stroke. A budget impact model (BIM) was developed to evaluate the economic impact associated with the reimbursement of MR-001 from a US payer perspective.
Source: Value in Health - June 1, 2023 Category: International Medicine & Public Health Authors: S. Kane, N. Jayawardena, M. Bourque, J. Lavanture, H. Roberts Source Type: research

Budget Impact of Left Atrial Appendage Occulusion in Patients with Atrial Fibrillation Contraindicated to Anticoagulation
Stroke is a leading public health problem in terms of mortality and economic burden in Korea. Anticoagulants are the mainstay for ischemic stroke prevention in atrial fibrillation (AF), but many patients have contraindications to these drugs. A number of catheter-based left atrial appendage occlusion (LAAO) devices devised to eliminate the major cause of thromboembolism in AF patients have been commercialized in Europe but are not yet available in Korea. The purpose of this study is to perform a budget impact analysis of LAAO in patients with AF contraindicated to anticoagulation.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: J.W. Park, M. Koullick, E. Han Tags: CARDIOVASCULAR DISORDERS - Cost Studies Source Type: research

Pages: 1  2